Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Hartmut Döhner

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Anatomy

Physiology

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Zenz Thorsten; Benner Axel; Dührsen Ulrich; Dürig Jan; Döhner Hartmut; Siffert Winfried; Stilgenbauer Stephan; Nückel Holger
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.
Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Böttcher S; Stilgenbauer S; Busch R; Brüggemann M; Raff T; Pott C; Fischer K; Fingerle-Rowson G; Döhner H; Hallek M; Kneba M; Ritgen M
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Hartmut Döhner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Zenz Thorsten; Benner Axel; Dührsen Ulrich; Dürig Jan; Döhner Hartmut; Siffert Winfried; Stilgenbauer Stephan; Nückel Holger
BCL2-938C>A polymorphism and disease progression in chronic lymphocytic leukemia.
Leukemia & lymphoma 2009;50(11):1837-42.
2009: Farfsing A; Engel F; Seiffert M; Hartmann E; Ott G; Rosenwald A; Stilgenbauer S; Döhner H; Boutros M; Lichter P; Pscherer A
Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(11):2018-26.
2009: Böttcher S; Stilgenbauer S; Busch R; Brüggemann M; Raff T; Pott C; Fischer K; Fingerle-Rowson G; Döhner H; Hallek M; Kneba M; Ritgen M
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(11):2007-17.
2009: Eichhorst Barbara F; Busch Raymonde; Stilgenbauer Stephan; Stauch Martina; Bergmann Manuela A; Ritgen Matthias; Kranzhöfer Nicole; Rohrberg Robert; Söling Ulrike; Burkhard Oswald; Westermann Anne; Goede Valentin; Schweighofer Carmen D; Fischer Kirsten; Fink Anna-Maria; Wendtner Clemens M; Brittinger Günter; Döhner Hartmut; Emmerich Bertold; Hallek Michael;
First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Blood 2009;114(16):3382-91.
2009: Giannopoulos K; Dmoszynska A; Kowal M; Wasik-Szczepanek E; Bojarska-Junak A; Rolinski J; Döhner H; Stilgenbauer S; Bullinger L
Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(10):1771-8.
2009: Zenz Thorsten; Häbe Sonja; Denzel Tina; Mohr Julia; Winkler Dirk; Bühler Andreas; Sarno Antonio; Groner Silja; Mertens Daniel; Busch Raymonde; Hallek Michael; Döhner Hartmut; Stilgenbauer Stephan
Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial.
Blood 2009;114(13):2589-97.
2009: Kayser Sabine; Schlenk Richard F; Londono Martina Correa; Breitenbuecher Frank; Wittke Kerstin; Du Juan; Groner Silja; Späth Daniela; Krauter Jürgen; Ganser Arnold; Döhner Hartmut; Fischer Thomas; Döhner Konstanze;
Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome.
Blood 2009;114(12):2386-92.
2009: Stilgenbauer Stephan; Zenz Thorsten; Winkler Dirk; Bühler Andreas; Schlenk Richard F; Groner Silja; Busch Raymonde; Hensel Manfred; Dührsen Ulrich; Finke Jürgen; Dreger Peter; Jäger Ulrich; Lengfelder Eva; Hohloch Karin; Söling Ulrike; Schlag Rudolf; Kneba Michael; Hallek Michael; Döhner Hartmut;
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3994-4001.
2009: Krauter Jürgen; Wagner Katharina; Schäfer Irina; Marschalek Rolf; Meyer Claus; Heil Gerhard; Schaich Markus; Ehninger Gerhard; Niederwieser Dietger; Krahl Rainer; Büchner Thomas; Sauerland Cristina; Schlegelberger Brigitte; Döhner Konstanze; Döhner Hartmut; Schlenk Richard F; Ganser Arnold
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3000-6.
2009: Gaidzik Verena Ingeborg; Schlenk Richard Friedrich; Moschny Simone; Becker Annegret; Bullinger Lars; Corbacioglu Andrea; Krauter Jürgen; Schlegelberger Brigitte; Ganser Arnold; Döhner Hartmut; Döhner Konstanze;
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group.
Blood 2009;113(19):4505-11.
2009: Zenz Thorsten; Mohr Julia; Eldering Eric; Kater Arnon P; Bühler Andreas; Kienle Dirk; Winkler Dirk; Dürig Jan; van Oers Marinus H J; Mertens Daniel; Döhner Hartmut; Stilgenbauer Stephan
miR-34a as part of the resistance network in chronic lymphocytic leukemia.
Blood 2009;113(16):3801-8.
2009: Giannopoulos K; Mertens D; Bühler A; Barth T F E; Idler I; Möller P; Kröber A; Greiner J; Chocholska S; Dmoszyñska A; Roliñski J; Döhner H; Stilgenbauer S; Schmitt M
The candidate immunotherapeutical target, the receptor for hyaluronic acid-mediated motility, is associated with proliferation and shows prognostic value in B-cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009;23(3):519-27.
2009: Schlenk Richard F; Döhner Konstanze; Kneba Michael; Götze Katharina; Hartmann Frank; Del Valle Francesco; Kirchen Heinz; Koller Elisabeth; Fischer Jörg T; Bullinger Lars; Habdank Marianne; Späth Daniela; Groner Silja; Krebs Bernhard; Kayser Sabine; Corbacioglu Andrea; Anhalt Andreas; Benner Axel; Fröhling Stefan; Döhner Hartmut;
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.
Haematologica 2009;94(1):54-60.
2009: Fei Fei; Yu Yingzhe; Schmitt Anita; Rojewski Markus Thomas; Chen Baoan; Götz Marlies; Döhner Hartmut; Bunjes Donald; Schmitt Michael
Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.
British journal of haematology 2009;144(2):195-205.
2009: Schwaenen Carsten; Viardot Andreas; Berger Hilmar; Barth Thomas F E; Bentink Stefan; Döhner Hartmut; Enz Martina; Feller Alfred C; Hansmann Martin-Leo; Hummel Michael; Kestler Hans A; Klapper Wolfram; Kreuz Markus; Lenze Dido; Loeffler Markus; Möller Peter; Müller-Hermelink Hans-Konrad; Ott German; Rosolowski Maciej; Rosenwald Andreas; Ruf Sandra; Siebert Reiner; Spang Rainer; Stein Harald; Truemper Lorenz; Lichter Peter; Bentz Martin; Wessendorf Swen;
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status.
Genes, chromosomes & cancer 2009;48(1):39-54.
2008: Zenz Thorsten; Benner Axel; Döhner Hartmut; Stilgenbauer Stephan
Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway.
Cell cycle (Georgetown, Tex.) 2008;7(24):3810-4.
2008: Greiner Jochen; Bullinger Lars; Guinn Barbara-ann; Döhner Hartmut; Schmitt Michael
Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7161-6.
2008: Buck Andreas K; Bommer Martin; Juweid Malik E; Glatting Gerhard; Stilgenbauer Stephan; Mottaghy Felix M; Schulz Melanie; Kull Thomas; Bunjes Donald; Möller Peter; Döhner Hartmut; Reske Sven N
First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(11):1756-62.
2008: Zenz Thorsten; Kröber Alexander; Scherer Katrin; Häbe Sonja; Bühler Andreas; Benner Axel; Denzel Tina; Winkler Dirk; Edelmann Jennifer; Schwänen Carsten; Döhner Hartmut; Stilgenbauer Stephan
Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up.
Blood 2008;112(8):3322-9.
2008: Fei Fei; Yu Yingzhe; Schmitt Anita; Rojewski Markus Thomas; Chen Baoan; Greiner Jochen; Götz Marlies; Guillaume Philippe; Döhner Hartmut; Bunjes Donald; Schmitt Michael
Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens.
Experimental hematology 2008;36(10):1297-308.
2008: Fröhling Stefan; Döhner Hartmut
Chromosomal abnormalities in cancer.
The New England journal of medicine 2008;359(7):722-34.
2008: Bloomfield Clara D; Marcucci Guido; Döhner Konstanze; Döhner Hartmut
Acute myeloid leukemia. Introduction.
Seminars in oncology 2008;35(4):324-5.
2008: Liso Arcangelo; Castiglione Filippo; Cappuccio Antonio; Stracci Fabrizio; Schlenk Richard F; Amadori Sergio; Thiede Christian; Schnittger Susanne; Valk Peter J M; Döhner Konstanze; Martelli Massimo F; Schaich Markus; Krauter Jürgen; Ganser Arnold; Martelli Maria P; Bolli Niccolò; Löwenberg Bob; Haferlach Torsten; Ehninger Gerhard; Mandelli Franco; Döhner Hartmut; Michor Franziska; Falini Brunangelo
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Haematologica 2008;93(8):1219-26.
2008: Döhner Konstanze; Döhner Hartmut
Molecular characterization of acute myeloid leukemia.
Haematologica 2008;93(7):976-82.
2008: Zenz Thorsten; Häbe Sonja; Benner Axel; Kienle Dirk; Döhner Hartmut; Stilgenbauer Stephan
The MDM2 -309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia.
Haematologica 2008;93(7):1111-3.
2008: Messerer Dorle; Engel Jutta; Hasford Joerg; Schaich Markus; Ehninger Gerhard; Sauerland Cristina; Büchner Thomas; Schumacher Andrea; Krahl Rainer; Niederwieser Dietger; Krauter Jürgen; Ganser Arnold; Creutzig Ursula; Döhner Hartmut; Schlenk Richard F;
Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia.
Haematologica 2008;93(6):826-33.
2008: Hallek Michael; Cheson Bruce D; Catovsky Daniel; Caligaris-Cappio Federico; Dighiero Guillaume; Döhner Hartmut; Hillmen Peter; Keating Michael J; Montserrat Emili; Rai Kanti R; Kipps Thomas J;
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
Blood 2008;111(12):5446-56.
2008: Zenz Thorsten; Mertens Daniel; Döhner Hartmut; Stilgenbauer Stephan
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications.
Leukemia & lymphoma 2008;49(5):864-73.
2008: Schlenk Richard F; Döhner Konstanze; Krauter Jürgen; Fröhling Stefan; Corbacioglu Andrea; Bullinger Lars; Habdank Marianne; Späth Daniela; Morgan Michael; Benner Axel; Schlegelberger Brigitte; Heil Gerhard; Ganser Arnold; Döhner Hartmut;
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
The New England journal of medicine 2008;358(18):1909-18.
2008: Yao Junxia; Bechter Clemens; Wiesneth Markus; Härter Georg; Götz Marlies; Germeroth Lothar; Guillaume Philippe; Hasan Ferishte; von Harsdorf Stephanie; Mertens Thomas; Michel Detlef; Döhner Hartmut; Bunjes Donald; Schmitt Michael; Schmitt Anita
Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(10):e96-105.
2008: Sander Sandrine; Bullinger Lars; Leupolt Elke; Benner Axel; Kienle Dirk; Katzenberger Tiemo; Kalla Jörg; Ott German; Müller-Hermelink Hans Konrad; Barth Thomas F E; Möller Peter; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
Haematologica 2008;93(5):680-7.
2008: Bullinger Lars; Döhner Konstanze; Kranz Raphael; Stirner Christoph; Fröhling Stefan; Scholl Claudia; Kim Young H; Schlenk Richard F; Tibshirani Robert; Döhner Hartmut; Pollack Jonathan R
An FLT3 gene-expression signature predicts clinical outcome in normal karyotype AML.
Blood 2008;111(9):4490-5.
2008: Schlenk Richard F; Pasquini Marcelo C; Pérez Waleska S; Zhang Mei-Jie; Krauter Jürgen; Antin Joseph H; Bashey Asad; Bolwell Brian J; Büchner Thomas; Cahn Jean-Yves; Cairo Mitchell S; Copelan Edward A; Cutler Corey S; Döhner Hartmut; Gale Robert Peter; Ilhan Osman; Lazarus Hillard M; Liesveld Jane L; Litzow Mark R; Marks David I; Maziarz Richard T; McCarthy Philip L; Nimer Stephen D; Sierra Jorge; Tallman Martin S; Weisdorf Daniel J; Horowitz Mary M; Ganser Arnold;
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):187-96.
2008: Creutzig Ursula; Büchner Thomas; Sauerland Maria C; Zimmermann Martin; Reinhardt Dirk; Döhner Hartmut; Schlenk Richard F
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Cancer 2008;112(3):562-71.
2008: Roos Göran; Kröber Alexander; Grabowski Pawel; Kienle Dirk; Bühler Andreas; Döhner Hartmut; Rosenquist Richard; Stilgenbauer Stephan
Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.
Blood 2008;111(4):2246-52.
2007: Fröhling Stefan; Scholl Claudia; Levine Ross L; Loriaux Marc; Boggon Titus J; Bernard Olivier A; Berger Roland; Döhner Hartmut; Döhner Konstanze; Ebert Benjamin L; Teckie Sewit; Golub Todd R; Jiang Jingrui; Schittenhelm Marcus M; Lee Benjamin H; Griffin James D; Stone Richard M; Heinrich Michael C; Deininger Michael W; Druker Brian J; Gilliland D Gary
Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles.
Cancer cell 2007;12(6):501-13.
2007: Wessendorf S; Barth T F E; Viardot A; Mueller A; Kestler H A; Kohlhammer H; Lichter P; Bentz M; Döhner H; Möller P; Schwaenen C
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(12):2463-9.
2007: Chen Jinfei; Schmitt Anita; Giannopoulos Krzysztof; Chen Baoan; Rojewski Markus; Döhner Hartmut; Bunjes Donald; Schmitt Michael
Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.
International journal of oncology 2007;31(5):1133-9.
2007: Kainz Birgit; Shehata Medhat; Bilban Martin; Kienle Dirk; Heintel Daniel; Krömer-Holzinger Elisabeth; Le Trang; Kröber Alexander; Heller Gerwin; Schwarzinger Ilse; Demirtas Dita; Chott Andreas; Döhner Hartmut; Zöchbauer-Müller Sabine; Fonatsch Christa; Zielinski Christoph; Stilgenbauer Stephan; Gaiger Alexander; Wagner Oswald; Jäger Ulrich
Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia.
International journal of cancer. Journal international du cancer 2007;121(9):1984-93.
2007: Zenz Thorsten; Döhner Hartmut; Stilgenbauer Stephan
Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
Best practice & research. Clinical haematology 2007;20(3):439-53.
2007: Stilgenbauer Stephan; Sander Sandrine; Bullinger Lars; Benner Axel; Leupolt Elke; Winkler Dirk; Kröber Alexander; Kienle Dirk; Lichter Peter; Döhner Hartmut
Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
Haematologica 2007;92(9):1242-5.
2007: Seiffert M; Stilgenbauer S; Döhner H; Lichter P
Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(9):1977-83.
2007: Bullinger Lars; Rücker Frank G; Kurz Stephan; Du Juan; Scholl Claudia; Sander Sandrine; Corbacioglu Andrea; Lottaz Claudio; Krauter Jürgen; Fröhling Stefan; Ganser Arnold; Schlenk Richard F; Döhner Konstanze; Pollack Jonathan R; Döhner Hartmut
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia.
Blood 2007;110(4):1291-300.
2007: Kienle Dirk; Katzenberger Tiemo; Ott German; Saupe Doreen; Benner Axel; Kohlhammer Holger; Barth Thomas F E; Höller Sylvia; Kalla Jörg; Rosenwald Andreas; Müller-Hermelink Hans Konrad; Möller Peter; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2770-7.
2007: Schaich Markus; Schlenk Richard F; Al-Ali Haifa K; Döhner Hartmut; Ganser Arnold; Heil Gerhard; Illmer Thomas; Krahl Rainer; Krauter Jürgen; Sauerland Cristina; Büchner Thomas; Ehninger Gerhard
Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Haematologica 2007;92(6):763-70.
2007: Chen Jinfei; Schmitt Anita; Chen Baoan; Rojewski Markus; Ringhoffer Mark; von Harsdorf Stephanie; Greiner Jochen; Guillaume Philippe; Döhner Hartmut; Bunjes Donald; Schmitt Michael
Imatinib impairs CD8+ T lymphocytes specifically directed against the leukemia-associated antigen RHAMM/CD168 in vitro.
Cancer immunology, immunotherapy : CII 2007;56(6):849-61.
2007: Kalla Claudia; Scheuermann Markus O; Kube Ina; Schlotter Magdalena; Mertens Daniel; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
European journal of cancer (Oxford, England : 1990) 2007;43(8):1328-35.
2007: Westermann Jörg; Kopp Joachim; van Lessen Antje; Hecker Ann-Christine; Baskaynak Gökben; le Coutre Philipp; Döhner Konstanze; Döhner Hartmut; Dörken Bernd; Pezzutto Antonio
Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
British journal of haematology 2007;137(4):297-306.
2007: Scholl Claudia; Bansal Dimple; Döhner Konstanze; Eiwen Karina; Huntly Brian J P; Lee Benjamin H; Rücker Frank G; Schlenk Richard F; Bullinger Lars; Döhner Hartmut; Gilliland D Gary; Fröhling Stefan
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis.
The Journal of clinical investigation 2007;117(4):1037-48.
2007: Heidel Florian; Cortes Jorge; Rücker Frank G; Aulitzky Walter; Letvak Laurie; Kindler Thomas; Huber Christoph; Döhner Hartmut; Kantarjian Hagop; Fischer Thomas
Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib.
Cancer 2007;109(5):907-14.
2007: Mrózek Krzysztof; Döhner Hartmut; Bloomfield Clara D
Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
Current opinion in hematology 2007;14(2):106-14.
2007: Ringhoffer Mark; Harsdorf Stephanie von; Schmitt Michael; Wiesneth Markus; Zenz Thorsten; Stilgenbauer Stephan; Greiner Jochen; Döhner Konstanze; Marx Martin; Döhner Hartmut; Bunjes Donald
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse.
British journal of haematology 2007;136(1):127-30.
2007: Döhner Hartmut
Implication of the molecular characterization of acute myeloid leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2007;():412-9.
2006: Schmitt Michael; Li Li; Giannopoulos Krzysztof; Chen Jinfei; Brunner Christian; Barth Thomas; Schmitt Anita; Wiesneth Markus; Döhner Konstanze; Döhner Hartmut; Greiner Jochen
Chronic myeloid leukemia cells express tumor-associated antigens eliciting specific CD8+ T-cell responses and are lacking costimulatory molecules.
Experimental hematology 2006;34(12):1709-19.
2006: Greiner Jochen; Döhner Hartmut; Schmitt Michael
Cancer vaccines for patients with acute myeloid leukemia--definition of leukemia-associated antigens and current clinical protocols targeting these antigens.
Haematologica 2006;91(12):1653-61.
2006: Estey Elihu; Döhner Hartmut
Acute myeloid leukaemia.
Lancet 2006;368(9550):1894-907.
2006: Buck Andreas K; Bommer Martin; Stilgenbauer Stephan; Juweid Malik; Glatting Gerhard; Schirrmeister Holger; Mattfeldt Torsten; Tepsic Djurdja; Bunjes Donald; Mottaghy Felix M; Krause Bernd J; Neumaier Bernd; Döhner Hartmut; Möller Peter; Reske Sven N
Molecular imaging of proliferation in malignant lymphoma.
Cancer research 2006;66(22):11055-61.
2006: Döhner Konstanze; Du Juan; Corbacioglu Andrea; Scholl Claudia; Schlenk Richard F; Döhner Hartmut
JAK2V617F mutations as cooperative genetic lesions in t(8;21)-positive acute myeloid leukemia.
Haematologica 2006;91(11):1569-70.
2006: Fröhling Stefan; Schlenk Richard F; Kayser Sabine; Morhardt Martina; Benner Axel; Döhner Konstanze; Döhner Hartmut;
Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.
Blood 2006;108(10):3280-8.
2006: Winkler Dirk; Döhner Hartmut; Stilgenbauer Stephan
Genetics, gene expression, and targeted therapies in chronic lymphocytic leukemia.
Current drug targets 2006;7(10):1313-27.
2006: von Baum H; Sigge A; Bommer M; Kern W V; Marre R; Döhner H; Kern P; Reuter S
Moxifloxacin prophylaxis in neutropenic patients.
The Journal of antimicrobial chemotherapy 2006;58(4):891-4.
2006: Zenz Thorsten; Ritgen Matthias; Dreger Peter; Kröber Alexander; Barth Thomas F; Schlenk Richard; Böttcher Sebastian; Hallek Michael J; Kneba Michael; Bunjes Donald; Döhner Hartmut; Stilgenbauer Stephan
Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia.
Blood 2006;108(6):2127-30.
2006: Rücker Frank G; Bullinger Lars; Schwaenen Carsten; Lipka Daniel B; Wessendorf Swen; Fröhling Stefan; Bentz Martin; Miller Simone; Scholl Claudia; Schlenk Richard F; Radlwimmer Bernhard; Kestler Hans A; Pollack Jonathan R; Lichter Peter; Döhner Konstanze; Döhner Hartmut
Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3887-94.
2006: Liebisch Peter; Döhner Hartmut
Cytogenetics and molecular cytogenetics in multiple myeloma.
European journal of cancer (Oxford, England : 1990) 2006;42(11):1520-9.
2006: Giannopoulos K; Li L; Bojarska-Junak A; Rolinski J; Dmoszynska A; Hus I; Greiner J; Renner C; Döhner H; Schmitt M
Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia.
International journal of oncology 2006;29(1):95-103.
2006: Rücker F G; Sander S; Döhner K; Döhner H; Pollack J R; Bullinger L
Molecular profiling reveals myeloid leukemia cell lines to be faithful model systems characterized by distinct genomic aberrations.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(6):994-1001.
2006: Pscherer Armin; Schliwka Julia; Wildenberger Kathrin; Mincheva Antoaneta; Schwaenen Carsten; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(8):1188-90.
2006: Saussele Susanne; Berger Ute; Aul Carlo; Büchner Thomas; Döhner Hartmut; Ehninger Gerhard; Ganser Arnold; Gökbuget Nicola; Hoelzer Dieter; Uberla Karl; Hehlmann Rüdiger
[Clinical research within the German competence net "acute and chronic leukemias"]
Medizinische Klinik (Munich, Germany : 1983) 2006;101(5):414-20.
2006: Mertens Daniel; Wolf Stephan; Tschuch Cordula; Mund Cora; Kienle Dirk; Ohl Sibylle; Schroeter Petra; Lyko Frank; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(20):7741-6.
2006: Seiler Till; Döhner Hartmut; Stilgenbauer Stephan
Risk stratification in chronic lymphocytic leukemia.
Seminars in oncology 2006;33(2):186-94.
2006: Engert Andreas; Bredenfeld Henning; Döhner Hartmut; Ho Anthony D; Schmitz Norbert; Berger Dietmar; Bacon Pamela; Skacel Tomas; Easton Valerie; Diehl Volker
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Haematologica 2006;91(4):546-9.
2006: Schlenk R F; Fröhling S; Hartmann F; Fischer J Th; Glasmacher A; Del Valle F; Götze K; Nerl C; Schoch R; Pralle H; Mergenthaler H G; Hensel M; Koller E; Kirchen H; Matzdorff A; Salwender H; Biedermann H G; Kremers S; Haase D; Benner A; Döhner K; Döhner H
Intensive consolidation versus oral maintenance therapy in patients 61 years or older with acute myeloid leukemia in first remission: results of second randomization of the AML HD98-B treatment Trial.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(4):748-50.
2006: Thorsélius Mia; Kröber Alexander; Murray Fiona; Thunberg Ulf; Tobin Gerard; Bühler Andreas; Kienle Dirk; Albesiano Emilia; Maffei Rossana; Dao-Ung Lan-Phuong; Wiley James; Vilpo Juhani; Laurell Anna; Merup Mats; Roos Göran; Karlsson Karin; Chiorazzi Nicholas; Marasca Roberto; Döhner Hartmut; Stilgenbauer Stephan; Rosenquist Richard
Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.
Blood 2006;107(7):2889-94.
2006: Wolf Stephan; Mertens Daniel; Pscherer Armin; Schroeter Petra; Winkler Dirk; Gröne Hermann-Josef; Hofele Christof; Hemminki Kari; Kumar Rajiv; Steineck Gunnar; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Ala228 variant of trail receptor 1 affecting the ligand binding site is associated with chronic lymphocytic leukemia, mantle cell lymphoma, prostate cancer, head and neck squamous cell carcinoma and bladder cancer.
International journal of cancer. Journal international du cancer 2006;118(7):1831-5.
2006: Wiehe Juliane M I; Niesler Carola; Torzewski Jan; Zimmermann Oliver; Wiesneth Markus; Schmitt Michael; Schwarz Klaus; Döhner Hartmut; Hombach Vinzenz; Greiner Jochen
Efficient transient genetic labeling of human CD34+ progenitor cells for in vivo application.
Regenerative medicine 2006;1(2):223-34.
2006: Kienle Dirk; Benner Axel; Kröber Alexander; Winkler Dirk; Mertens Daniel; Bühler Andreas; Seiler Till; Jäger Ulrich; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.
Blood 2006;107(5):2090-3.
2006: Campbell Peter J; Griesshammer Martin; Döhner Konstanze; Döhner Hartmut; Kusec Rajko; Hasselbalch Hans C; Larsen Thomas Stauffer; Pallisgaard Niels; Giraudier Stéphane; Le Bousse-Kerdilès Marie-Caroline; Desterke Christophe; Guerton Bernadette; Dupriez Brigitte; Bordessoule Dominique; Fenaux Pierre; Kiladjian Jean-Jacques; Viallard Jean-François; Brière Jean; Harrison Claire N; Green Anthony R; Reilly John T
V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.
Blood 2006;107(5):2098-100.
2006: Zenz Thorsten; Glatting Gerhard; Schlenk Richard F; Buchmann Inga; Döhner Hartmut; Reske Sven N; Bunjes Donald
Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study.
Haematologica 2006;91(2):285-6.
2006: Zenz Thorsten; Schlenk Richard F; Glatting Gerhard; Neumaier Bernd; Blumstein Norbert; Buchmann Inga; von Harsdorf Stephanie; Ringhoffer Mark; Wiesneth Markus; Keller Frieder; Kotzerke Jörg; Röttinger Erwin; Stilgenbauer Stephan; Döhner Hartmut; Reske Sven N; Bunjes Donald
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):278-86.
2006: Fröhling Stefan; Lipka Daniel B; Kayser Sabine; Scholl Claudia; Schlenk Richard F; Döhner Hartmut; Gilliland D Gary; Levine Ross L; Döhner Konstanze
Rare occurrence of the JAK2 V617F mutation in AML subtypes M5, M6, and M7.
Blood 2006;107(3):1242-3.
2006: Kröber Alexander; Bloehdorn Johannes; Hafner Sebastian; Bühler Andreas; Seiler Till; Kienle Dirk; Winkler Dirk; Bangerter Markus; Schlenk Richard F; Benner Axel; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(6):969-75.
2006: Binet Jacques-Louis; Caligaris-Cappio Federico; Catovsky Daniel; Cheson Bruce; Davis Tom; Dighiero Guillaume; Döhner Hartmut; Hallek Michael; Hillmen Peter; Keating Michael; Montserrat Emili; Kipps Thomas J; Rai Kanti;
Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.
Blood 2006;107(3):859-61.
2006: Eichhorst Barbara F; Busch Raymonde; Hopfinger Georg; Pasold Rita; Hensel Manfred; Steinbrecher Cordelia; Siehl Siegfried; Jäger Ulrich; Bergmann Manuela; Stilgenbauer Stephan; Schweighofer Carmen; Wendtner Clemens M; Döhner Hartmut; Brittinger Günter; Emmerich Bertold; Hallek Michael;
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia.
Blood 2006;107(3):885-91.
2006: Skogsberg S; Tobin G; Kröber A; Kienle D; Thunberg U; Aleskog A; Karlsson K; Laurell A; Merup M; Vilpo J; Sundström C; Roos G; Jernberg-Wiklund H; Döhner H; Nilsson K; Stilgenbauer S; Rosenquist R
The G(-248)A polymorphism in the promoter region of the Bax gene does not correlate with prognostic markers or overall survival in chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):77-81.
2005: Chen Bao-An; Bi Yan-Zhi; Ding Jia-Hua; Zhang Yan; Gao Chong; Sun Yun-Yu; Zhao Gang; Wang Jun; Cheng Jian; Sun Xue-Mei; Schmitt Michael; Döhner Hartmut
[Induction of immune tolerance for allogenic recipient mice by non-myeloablative bone marrow transplantation]
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2005;13(6):1054-7.
2005: Scholl Claudia; Schlenk Richard F; Eiwen Karina; Döhner Hartmut; Fröhling Stefan; Döhner Konstanze;
The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
Haematologica 2005;90(12):1626-34.
2005: Döhner Konstanze; Schlenk Richard F; Habdank Marianne; Scholl Claudia; Rücker Frank G; Corbacioglu Andrea; Bullinger Lars; Fröhling Stefan; Döhner Hartmut
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.
Blood 2005;106(12):3740-6.
2005: Heuser Michael; Wingen Luzie U; Steinemann Doris; Cario Gunnar; von Neuhoff Nils; Tauscher Marcel; Bullinger Lars; Krauter Juergen; Heil Gerhard; Döhner Hartmut; Schlegelberger Brigitte; Ganser Arnold
Gene-expression profiles and their association with drug resistance in adult acute myeloid leukemia.
Haematologica 2005;90(11):1484-92.
2005: Ringhoffer Mark; Blumstein Norbert; Neumaier Bernd; Glatting Gerhard; von Harsdorf Stephanie; Buchmann Inga; Wiesneth Markus; Kotzerke Jörg; Zenz Thorsten; Buck Andreas K; Schauwecker Peter; Stilgenbauer Stephan; Döhner Hartmut; Reske Sven N; Bunjes Donald
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
British journal of haematology 2005;130(4):604-13.
2005: Greiner Jochen; Li Li; Ringhoffer Mark; Barth Thomas F E; Giannopoulos Krzysztof; Guillaume Phillipe; Ritter Gerd; Wiesneth Markus; Döhner Hartmut; Schmitt Michael
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.
Blood 2005;106(3):938-45.
2005: Winkler D; Schneider C; Kröber A; Pasqualucci L; Lichter P; Döhner H; Stilgenbauer S
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1211-5.
2005: Heintel D; Kienle D; Shehata M; Kröber A; Kroemer E; Schwarzinger I; Mitteregger D; Le T; Gleiss A; Mannhalter C; Chott A; Schwarzmeier J; Fonatsch C; Gaiger A; Döhner H; Stilgenbauer S; Jäger U;
High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(7):1216-23.
2005: Li Li; Reinhardt Peter; Schmitt Anita; Barth Thomas F E; Greiner Jochen; Ringhoffer Mark; Döhner Hartmut; Wiesneth Markus; Schmitt Michael
Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigens.
Cancer immunology, immunotherapy : CII 2005;54(7):685-93.
2005: Kienle Dirk L; Korz Christian; Hosch Beate; Benner Axel; Mertens Daniel; Habermann Annett; Kröber Alexander; Jäger Ulrich; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3780-92.
2005: Schlenk R F; Germing U; Hartmann F; Glasmacher A; Fischer J T; del Valle y Fuentes F; Götze K; Pralle H; Nerl C; Salwender H; Grimminger W; Petzer A; Hensel M; Benner A; Zick L; Döhner K; Fröhling S; Döhner H;
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(6):978-83.
2005: Liebisch Peter; Eppinger Susanne; Schöpflin Christine; Stehle Gerd; Munzert Gerd; Döhner Hartmut; Schmid Mathias
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
Haematologica 2005;90(4):489-93.
2005: Reuter Stefan; Kern Winfried V; Sigge Anja; Döhner Hartmut; Marre Reinhard; Kern Peter; von Baum Heike
Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(8):1087-93.
2005: Fröhling Stefan; Schlenk Richard F; Krauter Jürgen; Thiede Christian; Ehninger Gerhard; Haase Detlef; Harder Lana; Kreitmeier Sylvia; Scholl Claudia; Caligiuri Michael A; Bloomfield Clara D; Döhner Hartmut; Döhner Konstanze
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
Genes, chromosomes & cancer 2005;42(4):427-32.
2005: Döhner Hartmut
The use of molecular markers in selecting therapy for CLL.
Clinical advances in hematology & oncology : H&O 2005;3(2):103-4.
2005: Fröhling Stefan; Kayser Sabine; Mayer Cora; Miller Simone; Wieland Christa; Skelin Silvia; Schlenk Richard F; Döhner Hartmut; Döhner Konstanze;
Diagnostic value of fluorescence in situ hybridization for the detection of genomic aberrations in older patients with acute myeloid leukemia.
Haematologica 2005;90(2):194-9.
2005: Kalla Claudia; Nentwich Hagen; Schlotter Magdalena; Mertens Daniel; Wildenberger Kathrin; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia disrupts two novel genes.
Genes, chromosomes & cancer 2005;42(2):128-43.
2005: Fiedler Walter; Serve Hubert; Döhner Hartmut; Schwittay Michael; Ottmann Oliver G; O'Farrell Anne-Marie; Bello Carlo L; Allred Randy; Manning William C; Cherrington Julie M; Louie Sharianne G; Hong Weiru; Brega Nicoletta M; Massimini Giorgio; Scigalla Paul; Berdel Wolfgang E; Hossfeld Dieter K
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease.
Blood 2005;105(3):986-93.
2005: Liebisch Peter; Scheck Daniel; Erné Seiichi Alvise; Wellmann Alexander; Wendl Christiane; Janczik Sibylle; Kolmus Sonja; Kröber Alexander; Einsele Hermann; Straka Christian; Goldschmidt Hartmut; Benner Axel; Stilgenbauer Stephan; Döhner Hartmut
Duplication of chromosome arms 9q and 11q: evidence for a novel, 14q32 translocation-independent pathogenetic pathway in multiple myeloma.
Genes, chromosomes & cancer 2005;42(1):78-81.
2005: Stilgenbauer S; Döhner H
Genotypic prognostic markers.
Current topics in microbiology and immunology 2005;294():147-64.
2004: Hehlmann R; Berger U; Aul C; Büchner Th; Döhner H; Ehninger G; Ganser A; Gökbuget N; Hoelzer D; Uberla K
[The competence network "acute and chronic leukemias"]
Deutsche medizinische Wochenschrift (1946) 2004;129(49):2660-5.
2004: Fröhling Stefan; Döhner Hartmut
Disruption of C/EBPalpha function in acute myeloid leukemia.
The New England journal of medicine 2004;351(23):2370-2.
2004: Schlenk R F; Fröhling S; Hartmann F; Fischer J Th; Glasmacher A; del Valle F; Grimminger W; Götze K; Waterhouse C; Schoch R; Pralle H; Mergenthaler H G; Hensel M; Koller E; Kirchen H; Preiss J; Salwender H; Biedermann H G; Kremers S; Griesinger F; Benner A; Addamo B; Döhner K; Haas R; Döhner H;
Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(11):1798-803.
2004: Haslinger Christian; Schweifer Norbert; Stilgenbauer Stephan; Döhner Hartmut; Lichter Peter; Kraut Norbert; Stratowa Christian; Abseher Roger
Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(19):3937-49.
2004: Böttcher S; Ritgen M; Pott C; Brüggemann M; Raff T; Stilgenbauer S; Döhner H; Dreger P; Kneba M
Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(10):1637-45.
2004: Ritgen Matthias; Stilgenbauer Stephan; von Neuhoff Nils; Humpe Andreas; Brüggemann Monika; Pott Christiane; Raff Thorsten; Kröber Alexander; Bunjes Donald; Schlenk Richard; Schmitz Norbert; Döhner Hartmut; Kneba Michael; Dreger Peter
Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.
Blood 2004;104(8):2600-2.
2004: Schlenk R F; Benner A; Krauter J; Büchner T; Sauerland C; Ehninger G; Schaich M; Mohr B; Niederwieser D; Krahl R; Pasold R; Döhner K; Ganser A; Döhner H; Heil G
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3741-50.
2004: Stilgenbauer Stephan; Döhner Hartmut
Molecular genetics and its clinical relevance.
Hematology/oncology clinics of North America 2004;18(4):827-48, viii.
2004: Ringhoffer Mark; Wiesneth Markus; Harsdorf Stephanie; Schlenk Richard F; Schmitt Anita; Reinhardt Peter P; Moessner Margit; Grimminger Wolfgang; Mertens Thomas; Reske Sven N; Döhner Hartmut; Bunjes Donald
CD34 cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients.
British journal of haematology 2004;126(4):527-35.
2004: Kohlhammer Holger; Schwaenen Carsten; Wessendorf Swen; Holzmann Karlheinz; Kestler Hans A; Kienle Dirk; Barth Thomas F E; Möller Peter; Ott German; Kalla Jörg; Radlwimmer Bernhard; Pscherer Armin; Stilgenbauer Stephan; Döhner Hartmut; Lichter Peter; Bentz Martin
Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions.
Blood 2004;104(3):795-801.
2004: Holzmann Karlheinz; Kohlhammer Holger; Schwaenen Carsten; Wessendorf Swen; Kestler Hans A; Schwoerer Alexandra; Rau Bettina; Radlwimmer Bernd; Döhner Hartmut; Lichter Peter; Gress Thomas; Bentz Martin
Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes.
Cancer research 2004;64(13):4428-33.
2004: Lyko Frank; Stach Dirk; Brenner Axel; Stilgenbauer Stephan; Döhner Hartmut; Wirtz Michaela; Wiessler Manfred; Schmitz Oliver J
Quantitative analysis of DNA methylation in chronic lymphocytic leukemia patients.
Electrophoresis 2004;25(10-11):1530-5.
2004: Büchner Thomas; Döhner Hartmut; Ehninger Gerhard; Ganser Arnold; Niederwieser Dietger; Hasford Joerg
Cross-trial networking in AML: a step forward rather than corner cutting.
Leukemia research 2004;28(6):649-50.
2004: Wendtner C-M; Ritgen M; Schweighofer C D; Fingerle-Rowson G; Campe H; Jäger G; Eichhorst B; Busch R; Diem H; Engert A; Stilgenbauer S; Döhner H; Kneba M; Emmerich B; Hallek M;
Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1093-101.
2004: Bullinger Lars; Döhner Konstanze; Bair Eric; Fröhling Stefan; Schlenk Richard F; Tibshirani Robert; Döhner Hartmut; Pollack Jonathan R
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.
The New England journal of medicine 2004;350(16):1605-16.
2004: Hehlmann R; Berger U; Aul C; Büchner T; Döhner H; Ehninger G; Ganser A; Hoelzer D; Gökbuget N; Uberla K
[Clinical research in the "acute and chronic leukemias"competence network ]
Der Internist 2004;45(4):384-92.
2004: Heintel D; Kroemer E; Kienle D; Schwarzinger I; Gleiss A; Schwarzmeier J; Marculescu R; Le T; Mannhalter C; Gaiger A; Stilgenbauer S; Döhner H; Fonatsch C; Jäger U;
High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):756-62.
2004: Dreger Peter; Stilgenbauer Stephan; Benner Axel; Ritgen Matthias; Kröber Alexander; Kneba Michael; Schmitz Norbert; Döhner Hartmut
The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status.
Blood 2004;103(7):2850-8.
2004: Zenz T; Roessner A; Thomas A; Fröhling S; Döhner H; Calabretta B; Dahéron L
hIan5: the human ortholog to the rat Ian4/Iddm1/lyp is a new member of the Ian family that is overexpressed in B-cell lymphoid malignancies.
Genes and immunity 2004;5(2):109-16.
2004: Fröhling Stefan; Schlenk Richard F; Stolze Ina; Bihlmayr Jörg; Benner Axel; Kreitmeier Sylvia; Tobis Karen; Döhner Hartmut; Döhner Konstanze
CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):624-33.
2004: Greiner Jochen; Ringhoffer Mark; Taniguchi Masanori; Li Li; Schmitt Anita; Shiku Hiroshi; Döhner Hartmut; Schmitt Michael
mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies.
International journal of cancer. Journal international du cancer 2004;108(5):704-11.
2004: Schwaenen Carsten; Nessling Michelle; Wessendorf Swen; Salvi Tatjana; Wrobel Gunnar; Radlwimmer Bernhard; Kestler Hans A; Haslinger Christian; Stilgenbauer Stephan; Döhner Hartmut; Bentz Martin; Lichter Peter
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(4):1039-44.
2003: Liebisch P; Wendl C; Wellmann A; Kröber A; Schilling G; Goldschmidt H; Einsele H; Straka C; Bentz M; Stilgenbauer S; Döhner H
High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2535-7.
2003: Döhner Konstanze; Tobis Karen; Bischof Tobias; Hein Stefan; Schlenk Richard F; Fröhling Stefan; Döhner Hartmut
Mutation analysis of the transcription factor PU.1 in younger adults (16 to 60 years) with acute myeloid leukemia: a study of the AML Study Group Ulm (AMLSG ULM).
Blood 2003;102(10):3850; author reply 3850-1.
2003: Scholl Claudia; Breitinger Heike; Schlenk Richard F; Döhner Hartmut; Fröhling Stefan; Döhner Konstanze;
Development of a real-time RT-PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia.
Genes, chromosomes & cancer 2003;38(3):274-80.
2003: Zenz T; Döhner H; Bunjes D
Transfusion-free reduced-intensity conditioned allogeneic stem cell transplantation in a Jehovah's witness.
Bone marrow transplantation 2003;32(4):437-8.
2003: Schlenk R F; Benner A; Hartmann F; del Valle F; Weber C; Pralle H; Fischer J Th; Gunzer U; Pezzutto A; Weber W; Grimminger W; Preiss J; Hensel M; Fröhling S; Döhner K; Haas R; Döhner H;
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(8):1521-8.
2003: Greiner Jochen; Ringhoffer Mark; Taniguchi Masanori; Hauser Thomas; Schmitt Anita; Döhner Hartmut; Schmitt Michael
Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia.
International journal of cancer. Journal international du cancer 2003;106(2):224-31.
2003: Li Li; Schmitt Anita; Reinhardt Peter; Greiner Jochen; Ringhoffer Mark; Vaida Bianca; Bommer Martin; Vollmer Markus; Wiesneth Markus; Döhner Hartmut; Schmitt Michael
Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Cancer immunity : a journal of the Academy of Cancer Immunology 2003;3():8.
2003: Liebisch Peter; Viardot Andreas; Bassermann Nicole; Wendl Christiane; Roth Katrin; Goldschmidt Hartmut; Einsele Hermann; Straka Christian; Stilgenbauer Stephan; Döhner Hartmut; Bentz Martin
Value of comparative genomic hybridization and fluorescence in situ hybridization for molecular diagnostics in multiple myeloma.
British journal of haematology 2003;122(2):193-201.
2003: Viardot Andreas a; Barth Thomas F E; Möller Peter; Döhner Hartmut; Bentz Martin
Cytogenetic evolution of follicular lymphoma.
Seminars in cancer biology 2003;13(3):183-90.
2003: Schwaenen C; Wessendorf S; Kestler H A; Döhner H; Lichter P; Bentz M
DNA microarray analysis in malignant lymphomas.
Annals of hematology 2003;82(6):323-32.
2003: Vollmer Markus; Li Li; Schmitt Anita; Greiner Jochen; Reinhardt Peter; Ringhoffer Mark; Wiesneth Markus; Döhner Hartmut; Schmitt Michael
Expression of human leucocyte antigens and co-stimulatory molecules on blasts of patients with acute myeloid leukaemia.
British journal of haematology 2003;120(6):1000-8.
2003: Wessendorf Swen; Schwaenen Carsten; Kohlhammer Holger; Kienle Dirk; Wrobel Gunnar; Barth Thomas F E; Nessling Michelle; Möller Peter; Döhner Hartmut; Lichter Peter; Bentz Martin
Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization.
Oncogene 2003;22(9):1425-9.
2003: Stach Dirk; Schmitz Oliver J; Stilgenbauer Stephan; Benner Axel; Döhner Hartmut; Wiessler Manfred; Lyko Frank
Capillary electrophoretic analysis of genomic DNA methylation levels.
Nucleic acids research 2003;31(2):E2.
2002: Viardot Andreas; Möller Peter; Högel Josef; Werner Kirsten; Mechtersheimer Gunhild; Ho Anthony D; Ott German; Barth Thomas F E; Siebert Reiner; Gesk Stefan; Schlegelberger Brigitte; Döhner Hartmut; Bentz Martin
Clinicopathologic correlations of genomic gains and losses in follicular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4523-30.
2002: Büchner Thomas; Döhner Hartmut; Ehninger Gerhard; Ganser Arnold; Hasford Jörg;
Up-front randomization and common standard arm: a proposal for comparing AML treatment strategies between different studies.
Leukemia research 2002;26(12):1073-5.
2002: Fröhling Stefan; Schlenk Richard F; Breitruck Jochen; Benner Axel; Kreitmeier Sylvia; Tobis Karen; Döhner Hartmut; Döhner Konstanze;
Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.
Blood 2002;100(13):4372-80.
2002: Munzert Gerd; Kirchner Dieter; Stobbe Heike; Bergmann Lothar; Schmid Roland M; Döhner Hartmut; Heimpel Hermann
Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Blood 2002;100(10):3749-56.
2002: Hallek M; Bergmann M; Brittinger G; Döhner H; Dreger P; Herold M; Hopfinger G; Jäger U; Knauf W; Nerl C; Rummel M; Schmitt B; Wendtner C M; Emmerich B
[Chronic lymphatic leukemia. Current therapy concepts]
Der Internist 2002;43(10):1245-54.
2002: Greiner Jochen; Ringhoffer Mark; Taniguchi Masanori; Schmitt Anita; Kirchner Dieter; Krähn Gertraud; Heilmann Volker; Gschwend Jürgen; Bergmann Lothar; Döhner Hartmut; Schmitt Michael
Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia.
Experimental hematology 2002;30(9):1029-35.
2002: Stilgenbauer Stephan; Döhner Hartmut
Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy.
The New England journal of medicine 2002;347(6):452-3.
2002: Döhner Konstanze; Tobis Karen; Ulrich Regina; Fröhling Stefan; Benner Axel; Schlenk Richard F; Döhner Hartmut
Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(15):3254-61.
2002: Kröber Alexander; Seiler Till; Benner Axel; Bullinger Lars; Brückle Elsbeth; Lichter Peter; Döhner Hartmut; Stilgenbauer Stephan
V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Blood 2002;100(4):1410-6.
2002: Barth Thomas F E; Bentz Martin; Leithäuser Frank; Stilgenbauer Stephan; Siebert Reiner; Schlotter Magdalena; Schlenk Richard F; Döhner Hartmut; Möller Peter
Pathogenic complexity of gastric B-cell lymphoma.
Blood 2002;100(3):1095-6; author reply 1096-7.
2002: Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(6):993-1007.
2002: Korz Christian; Pscherer Armin; Benner Axel; Mertens Daniel; Schaffner Claudia; Leupolt Elke; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes.
Blood 2002;99(12):4554-61.
2002: Mertens Daniel; Wolf Stephan; Schroeter Petra; Schaffner Claudia; Döhner Hartmut; Stilgenbauer Stephan; Lichter Peter
Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia.
Blood 2002;99(11):4116-21.
2002: Fröhling Stefan; Skelin Silvia; Liebisch Claudia; Scholl Claudia; Schlenk Richard F; Döhner Hartmut; Döhner Konstanze;
Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(10):2480-5.
2002: Buchmann Inga; Bunjes Donald; Kotzerke Jörg; Martin Hans; Glatting Gerhard; Seitz Ulrike; Rattat Dirk; Buck Andreas; Döhner Hartmut; Reske Sven N
Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Cancer biotherapy & radiopharmaceuticals 2002;17(2):151-63.
2002: Schlenk R F; Hartmann F; Hensel M; Jung W; Weber-Nordt R; Gabler A; Haas R; Ho A D; Trümper L; Döhner H
Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(4):581-6.
2002: Schirrmeister H; Bommer M; Buck A K; Müller S; Messer P; Bunjes D; Döhner H; Bergmann L; Reske S N
Initial results in the assessment of multiple myeloma using 18F-FDG PET.
European journal of nuclear medicine and molecular imaging 2002;29(3):361-6.
2002: Wessendorf Swen; Fritz Björn; Wrobel Gunnar; Nessling Michelle; Lampel Stefan; Göettel Daniel; Küepper Manfred; Joos Stefan; Hopman Ton; Kokocinski Felix; Döhner Hartmut; Bentz Martin; Schwäenen Carsten; Lichter Peter
Automated screening for genomic imbalances using matrix-based comparative genomic hybridization.
Laboratory investigation; a journal of technical methods and pathology 2002;82(1):47-60.
2001: Ringhoffer M; Döhner K; Scheil S; Wilts H; Mertens T; Grimminger W; Döhner H; Bunjes D
Fatal outcome in a patient developing Epstein-Barr virus-associated lymphoproliferative disorder (EBV-LPD) without measurable disease.
Bone marrow transplantation 2001;28(6):615-8.
2001: Hallek M; Schmitt B; Wilhelm M; Busch R; Kröber A; Fostitsch H P; Sezer O; Herold M; Knauf W; Wendtner C M; Kuse R; Freund M; Franke A; Schriever F; Nerl C; Döhner H; Thiel E; Hiddemann W; Brittinger G; Emmerich B;
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.
British journal of haematology 2001;114(2):342-8.
2001: Bunjes D; Buchmann I; Duncker C; Seitz U; Kotzerke J; Wiesneth M; Dohr D; Stefanic M; Buck A; Harsdorf S V; Glatting G; Grimminger W; Karakas T; Munzert G; Döhner H; Bergmann L; Reske S N
Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study.
Blood 2001;98(3):565-72.
2001: Barth T F; Bentz M; Leithäuser F; Stilgenbauer S; Siebert R; Schlotter M; Schlenk R F; Döhner H; Möller P
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract.
Genes, chromosomes & cancer 2001;31(4):316-25.
2001: Reske S N; Bunjes D; Buchmann I; Seitz U; Glatting G; Neumaier B; Kotzerke J; Buck A; Martin H; Döhner H; Bergmann L
Targeted bone marrow irradiation in the conditioning of high-risk leukaemia prior to stem cell transplantation.
European journal of nuclear medicine 2001;28(7):807-15.
2001: Marcucci G; Caligiuri M A; Döhner H; Archer K J; Schlenk R F; Döhner K; Maghraby E A; Bloomfield C D
Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(7):1072-80.
2001: Seute A; Sinn H P; Schlenk R F; Emig R; Wallwiener D; Grischke E M; Hohaus S; Döhner H; Haas R; Bentz M
Clinical relevance of genomic aberrations in homogeneously treated high-risk stage II/III breast cancer patients.
International journal of cancer. Journal international du cancer 2001;93(1):80-4.
2001: Barth T F; Bentz M; Döhner H; Möller P
Molecular aspects of B-cell lymphomas of the gastrointestinal tract.
Clinical lymphoma 2001;2(1):57-64.
2001: Wolf S; Mertens D; Schaffner C; Korz C; Döhner H; Stilgenbauer S; Lichter P
B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions.
Human molecular genetics 2001;10(12):1275-85.
2001: Fröhling S; Nakabayashi K; Scherer S W; Döhner H; Döhner K
Mutation analysis of the origin recognition complex subunit 5 (ORC5L) gene in adult patients with myeloid leukemias exhibiting deletions of chromosome band 7q22.
Human genetics 2001;108(4):304-9.
2001: Bentz M; Barth T F; Brüderlein S; Bock D; Schwerer M J; Baudis M; Joos S; Viardot A; Feller A C; Müller-Hermelink H K; Lichter P; Döhner H; Möller P
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line.
Genes, chromosomes & cancer 2001;30(4):393-401.
2001: Stratowa C; Löffler G; Lichter P; Stilgenbauer S; Haberl P; Schweifer N; Döhner H; Wilgenbus K K
CDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.
International journal of cancer. Journal international du cancer 2001;91(4):474-80.
2001: Wessendorf S; Lichter P; Schwänen C; Fritz B; Baudis M; Walenta K; Kloess M; Döhner H; Bentz M
Potential of chromosomal and matrix-based comparative genomic hybridization for molecular diagnostics in lymphomas.
Annals of hematology 2001;80 Suppl 3():B35-7.
2000: Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
Genomic aberrations and survival in chronic lymphocytic leukemia.
The New England journal of medicine 2000;343(26):1910-6.
2000: Mertens D; Wolf S; Bullinger L; Ohl S; Schaffner C; Döhner H; Stilgenbauer S; Lichter P
BCMSUN, a candidate gene for B-cell chronic lymphocytic leukemia and mantle-cell lymphoma, has an independently expressed homolog on 1p22-p31, BCMSUN-like.
International journal of cancer. Journal international du cancer 2000;88(5):692-7.
2000: Kalla J; Stilgenbauer S; Schaffner C; Wolf S; Ott G; Greiner A; Rosenwald A; Döhner H; Müller-Hermelink H K; Lichter P
Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(11):1967-74.
2000: Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(8):1490-2.
2000: Barth T F; Benner A; Bentz M; Döhner H; Möller P; Lichter P
Risk of false positive results in comparative genomic hybridization.
Genes, chromosomes & cancer 2000;28(3):353-7.
2000: Ho A D; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Seminars in oncology 2000;27(2 Suppl 5):52-7.
2000: Barth T F; Leithäuser F; Döhner H; Bentz M; Pawlita M; Schmid U; Möller P
Primary gastric apoptosis-rich T-cell lymphoma co-expressing CD4, CD8, and cytotoxic molecules.
Virchows Archiv : an international journal of pathology 2000;436(4):357-64.
2000: Stilgenbauer S; Lichter P; Döhner H
Genetic features of B-cell chronic lymphocytic leukemia.
Reviews in clinical and experimental hematology 2000;4(1):48-72.
2000: Gahn B; Brittinger G; Dölken G; Döhner H; Emmerich B; Franke A; Freund M; Huber C; Kuse R; Scholten T; Hiddemann W
Multicenter phase II study of oral idarubicin in treated and untreated patients with B-chronic lymphocytic leukemia.
Leukemia & lymphoma 2000;37(1-2):169-73.
2000: Schaffner C; Idler I; Stilgenbauer S; Döhner H; Lichter P
Mantle cell lymphoma is characterized by inactivation of the ATM gene.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(6):2773-8.
2000: Bentz M; Plesch A; Bullinger L; Stilgenbauer S; Ott G; Müller-Hermelink H K; Baudis M; Barth T F; Möller P; Lichter P; Döhner H
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.
Genes, chromosomes & cancer 2000;27(3):285-94.
2000: Stilgenbauer S; Schaffner C; Winkler D; Ott G; Leupolt E; Bentz M; Möller P; Müller-Hermelink H K; James M R; Lichter P; Döhner H
The ATM gene in the pathogenesis of mantle-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():127-30.
1999: Ho A D; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(12):1493-8.
1999: Barth T F; Döhner H; Möller P; Bentz M
Chromosomal aberrations in lymphomas of the gastrointestinal tract.
Leukemia & lymphoma 1999;36(1-2):25-32.
1999: Stilgenbauer S; Winkler D; Ott G; Schaffner C; Leupolt E; Bentz M; Möller P; Müller-Hermelink H K; James M R; Lichter P; Döhner H
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma.
Blood 1999;94(9):3262-4.
1999: Nessling M; Solinas-Toldo S; Lichter P; Reifenberger G; Wolter M; Möller P; Döhner H; Bentz M
Genomic imbalances are rare in hairy cell leukemia.
Genes, chromosomes & cancer 1999;26(2):182-3.
1999: Stilgenbauer S; Bullinger L; Benner A; Wildenberger K; Bentz M; Döhner K; Ho A D; Lichter P; Döhner H
Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(9):1331-4.
1999: Schaffner C; Stilgenbauer S; Rappold G A; Döhner H; Lichter P
Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.
Blood 1999;94(2):748-53.
1999: Bentz M; Stilgenbauer S; Lichter P; Döhner H
Interphase FISH in chronic lymphoproliferative disorders and comparative genomic hybridisation in the study of lymphomas.
Haematologica 1999;84 Suppl EHA-4():102-6.
1999: Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
Journal of molecular medicine (Berlin, Germany) 1999;77(2):266-81.
1999: Sembries S; Pahl H; Stilgenbauer S; Döhner H; Schriever F
Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion.
Blood 1999;93(2):624-31.
1998: Döhner K; Brown J; Hehmann U; Hetzel C; Stewart J; Lowther G; Scholl C; Fröhling S; Cuneo A; Tsui L C; Lichter P; Scherer S W; Döhner H
Molecular cytogenetic characterization of a critical region in bands 7q35-q36 commonly deleted in malignant myeloid disorders.
Blood 1998;92(11):4031-5.
1998: Barth T F; Döhner H; Werner C A; Stilgenbauer S; Schlotter M; Pawlita M; Lichter P; Möller P; Bentz M
Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract.
Blood 1998;91(11):4321-30.
1998: Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Oncogene 1998;16(14):1891-7.
1998: Stilgenbauer S; Döhner K; Bentz M; Lichter P; Döhner H
Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia.
Annals of hematology 1998;76(3-4):101-10.
1998: Bentz M; Plesch A; Stilgenbauer S; Döhner H; Lichter P
Minimal sizes of deletions detected by comparative genomic hybridization.
Genes, chromosomes & cancer 1998;21(2):172-5.
1998: Werner C A; Döhner H; Barth T F; Stilgenbauer S; Plesch A; Lichter P; Bentz M
Molecular cytogenetic analysis of low-grade B-cell neoplasias: a comparative genomic hybridization study.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;144():53-60.
1998: Fischer K; Brown J; Scherer S W; Schramm P; Stewart J; Fugazza G; Pascheberg U; Peter W; Tsui L C; Lichter P; Döhner H
Delineation of genomic regions in chromosome band 7q22 commonly deleted in myeloid leukemias.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;144():46-52.
1997: Solinas-Toldo S; Lampel S; Stilgenbauer S; Nickolenko J; Benner A; Döhner H; Cremer T; Lichter P
Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.
Genes, chromosomes & cancer 1997;20(4):399-407.
1997: Schlenk R F; Döhner H; Pförsich M; Benner A; Fischer K; Hartmann F; Fischer J T; Weber W; Gunzer U; Pralle H; Haas R
Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone.
British journal of haematology 1997;99(2):386-93.
1997: Dreyling M H; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink H K; Bentz M; Hiddemann W; Döhner H
Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Cancer research 1997;57(20):4608-14.
1997: Stilgenbauer S; Schaffner C; Litterst A; Liebisch P; Gilad S; Bar-Shira A; James M R; Lichter P; Döhner H
Biallelic mutations in the ATM gene in T-prolymphocytic leukemia.
Nature medicine 1997;3(10):1155-9.
1997: Werner C A; Döhner H; Joos S; Trümper L H; Baudis M; Barth T F; Ott G; Möller P; Lichter P; Bentz M
High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.
The American journal of pathology 1997;151(2):335-42.
1997: Fischer K; Bentz M; Döhner H
[Fluorescence in-situ hybridization (FISH). Method and application]
Medizinische Klinik (Munich, Germany : 1983) 1997;92(5):279-83.
1997: Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1997;11 Suppl 2():S19-24.
1997: Döhner H; Stilgenbauer S; James M R; Benner A; Weilguni T; Bentz M; Fischer K; Hunstein W; Lichter P
11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.
Blood 1997;89(7):2516-22.
1997: Fischer K; Fröhling S; Scherer S W; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui L C; Lichter P; Döhner H
Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Blood 1997;89(6):2036-41.
1996: Fischer K; Scholl C; Sàlat J; Fröhling S; Schlenk R; Bentz M; Stilgenbauer S; Lichter P; Döhner H
Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia.
Blood 1996;88(10):3962-71.
1996: Stilgenbauer S; Liebisch P; James M R; Schröder M; Schlegelberger B; Fischer K; Bentz M; Lichter P; Döhner H
Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(21):11837-41.
1996: Lichter P; Fischer K; Joos S; Fink T; Baudis M; Potkul R K; Ohl S; Solinas-Toldo S; Weber R; Stilgenbauer S; Bentz M; Döhner H
Efficacy of current molecular cytogenetic protocols for the diagnosis of chromosome aberrations in tumor specimens.
Cytokines and molecular therapy 1996;2(3):163-9.
1996: Bentz M; Werner C A; Döhner H; Joos S; Barth T F; Siebert R; Schröder M; Stilgenbauer S; Fischer K; Möller P; Lichter P
High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma.
Blood 1996;88(4):1437-44.
1996: Tosi S; Cabot G; Giudici G; Attuati V; Morandi P; Rambaldi A; Döhner H; Biondi A
Detection of the breakpoint cluster region-ABL fusion in chronic myeloid leukemia with variant Philadelphia chromosome translocations by in situ hybridization.
Cancer genetics and cytogenetics 1996;89(2):153-6.
1996: Cabot G P; Bentz M; Scholl C; Moos M; Fischer K; Lichter P; Döhner H
High incidence of a second BCR-ABL fusion in chronic myeloid leukemia revealed by interphase cytogenetic analysis on blood and bone marrow smears.
Cancer genetics and cytogenetics 1996;87(2):107-11.
1996: Haas R; Moos M; Möhle R; Döhner H; Witt B; Goldschmidt H; Murea S; Flentje M; Wannenmacher M; Hunstein W
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma.
Bone marrow transplantation 1996;17(2):149-55.
1995: Bentz M; Döhner H; Werner C A; Huck K; Baudis M; Joos S; Schlegelberger B; Trümper L H; Feller A C; Pfreundschuh M
Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():83-7.
1995: Döhner H; Stilgenbauer S; Fischer K; Schröder M; Bentz M; Lichter P
Diagnosis and monitoring of chromosome aberrations in hematological malignancies by fluorescence in situ hybridization.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():76-82.
1995: Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():42-51.
1995: Haas R; Murea S; Goldschmidt H; Döhner H; Moos M; Witt B; Eugenhart R; Wannenmacher M; Hunstein W
High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphoma.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():28-35.
1995: Stilgenbauer S; Leupolt E; Ohl S; Weiss G; Schröder M; Fischer K; Bentz M; Lichter P; Döhner H
Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-cell chronic lymphocytic leukemia revealed by fluorescence in situ hybridization.
Cancer research 1995;55(16):3475-7.
1995: Bentz M; Huck K; du Manoir S; Joos S; Werner C A; Fischer K; Döhner H; Lichter P
Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses.
Blood 1995;85(12):3610-8.
1995: Döhner H; Fischer K; Bentz M; Hansen K; Benner A; Cabot G; Diehl D; Schlenk R; Coy J; Stilgenbauer S
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias.
Blood 1995;85(6):1580-9.
1995: Bentz M; Döhner H; Huck K; Schütz B; Ganser A; Joos S; du Manoir S; Lichter P
Comparative genomic hybridization in the investigation of myeloid leukemias.
Genes, chromosomes & cancer 1995;12(3):193-200.
1994: Döhner H; Pilz T; Fischer K; Cabot G; Diehl D; Fink T; Stilgenbauer S; Bentz M; Lichter P
Molecular cytogenetic analysis of RB-1 deletions in chronic B-cell leukemias.
Leukemia & lymphoma 1994;16(1-2):97-103.
1994: Bentz M; Döhner H; Cabot G; Lichter P
Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(9):1447-52.
1994: Bentz M; Cabot G; Moos M; Speicher M R; Ganser A; Lichter P; Döhner H
Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization.
Blood 1994;83(7):1922-8.
1993: Kauczor H U; Bentz M; Bischoff H; Gückel F; Döhner H; Brix G; van Kaick G
[Bone marrow involvement in Hodgkin's disease: MR tomography and chemical-shift imaging]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1993;159(6):555-61.
1993: Haas R; Ho A D; Del Valle F; Fischer J T; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
Seminars in oncology 1993;20(6 Suppl 8):20-6.
1993: Bentz M; Schröder M; Herz M; Stilgenbauer S; Lichter P; Döhner H
Detection of trisomy 8 on blood smears using fluorescence in situ hybridization.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(5):752-7.
1993: Schirren C A; Völpel H; Hoffmann J C; Henning S W; Qiao L; Autschbach F; Dengler T J; Döhner H; Meuer S C
Biological response modifiers render tumor cells susceptible to autologous effector mechanisms by influencing adhesion receptors.
Leukemia & lymphoma 1993;10(1-2):25-33.
1993: Stilgenbauer S; Döhner H; Bulgay-Mörschel M; Weitz S; Bentz M; Lichter P
High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics.
Blood 1993;81(8):2118-24.
1993: Döhner H; Ho A D; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
Journal of the National Cancer Institute 1993;85(8):658-62.
1993: Döhner H; Pohl S; Bulgay-Mörschel M; Stilgenbauer S; Bentz M; Lichter P
Trisomy 12 in chronic lymphoid leukemias--a metaphase and interphase cytogenetic analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(4):516-20.
1993: du Manoir S; Speicher M R; Joos S; Schröck E; Popp S; Döhner H; Kovacs G; Robert-Nicoud M; Lichter P; Cremer T
Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization.
Human genetics 1993;90(6):590-610.
1992: Döhner H; Ehrhardt R
[The importance of bone marrow examination for hemoblastoses]
Der Radiologe 1992;32(10):481-4.
1991: Bentz M; Döhner H; Gückel F; Semmler W; Kauczor H U; van Kaick G; Ho A D; Hunstein W
Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(10):905-7.
1989: Döhner H; Gückel F; Knauf W; Semmler W; van Kaick G; Ho A D; Hunstein W
Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy.
British journal of haematology 1989;73(1):12-7.
1989: Gückel F; Döhner H; Knauf W; Ho A D; Semmler W; van Kaick G
[MR tomography detection of bone marrow infiltration by malignant lymphomas]
Onkologie 1989;12 Suppl 1():34-7.
1989: Gückel F; Semmler W; Döhner H; Knauf W; Görich J; Ho A D; van Kaick G
[NMR tomographic imaging of bone marrow infiltrates in malignant lymphoma]
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 1989;150(1):26-31.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Hartmut Döhner

Research Profile (preview)

Disorders

Procedures

Anatomy

Physiology

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Hartmut Döhner (preview)

All Publications